How engineers and drug developers are working to change childhood cancer’s deadly calculus

A non-profit organization merges engineering and biology to accelerate drug development for childhood cancers. A non-profit organization merges engineering and biology to accelerate drug development for childhood cancers.

Saved in:
Bibliographic Details
Published in:Nature (London) 2022-06, Vol.606 (7912), p.214-215
Main Author: Landhuis, Esther
Format: Article
Language:English
Subjects:
631/154
631/67
692/700
Calculi
Child
Engineering
Humanities and Social Sciences
Humans
multidisciplinary
Neoplasms - epidemiology
Science
Technology Feature
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A non-profit organization merges engineering and biology to accelerate drug development for childhood cancers. A non-profit organization merges engineering and biology to accelerate drug development for childhood cancers.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-022-01513-5